Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01451697 · ClinicalTrials.gov registry record · Early Phase 1

Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding

A Early Phase 1 study, sponsored by Hartford Hospital.

Completed
Registry status
Early Phase 1
Development phase
20
Enrollment target

NCT01451697 is a Early Phase 1 study that has completed, run by Hartford Hospital. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01451697, a Early Phase 1 study, has completed, sponsored by Hartford Hospital.

COMPLETED
Registry status
Early Phase 1
Development phase
20 participants
Enrollment target

Study Summary

The primary aim of this pilot randomized controlled trial is to examine whether cognitive remediation, compared to a placebo, improves attention and related cognitive functions in patients with compulsive hoarding. The primary hypothesis is that compulsive hoarding patients who are treated with cognitive remediation will demonstrate improved cognitive skills at post-treatment compared to patients receiving placebo. This will be especially true of attention; memory and executive function skills may also be improved.

Interventions

  • BEHAVIORAL Cognitive Remediation
  • BEHAVIORAL Control (Placebo)

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-07
Est. Completion 2012-10
Phase Early Phase 1

Sponsor

Hartford Hospital

75 total trials

What the Registry Record Tells You About NCT01451697

The ClinicalTrials.gov registry entry for NCT01451697 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cognitive Remediation is the first listed.

NCT01451697 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01451697 about?

NCT01451697 is a clinical study titled "Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding". The primary aim of this pilot randomized controlled trial is to examine whether cognitive remediation, compared to a placebo, improves attention and related cognitive functions in patients with compulsive hoarding. The primary hypothesis is that compulsive hoarding patients who are treated with cogn...

What is the current status of trial NCT01451697?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01451697?

The interventions under investigation include: Cognitive Remediation (BEHAVIORAL), Control (Placebo) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01451697?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.